The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "An Update on the On-Sale Bar: Helsinn at the Supreme Court" on July 19, 2018 from 2:00 to 3:00 pm (ET). John Duffy of the University of Virginia, Jennifer Johnson of DuPont, and Christopher Loh of Fitzpatrick, Cella, Harper & Scinto will review the current status quo after two significant Federal Circuit decisions in recent years on the on-sale and public use bars, Merck & CIE v. Watson Labs and The Medicines Co. v. Hospira. The panel will also consider what questions may remain unanswered after Helsinn v. Teva, such as (1) does a fully-secret sales offer count to bar a patent under section 102? And (2) even if it serves as a bar to patentability under section 102, to what extent does a secret sale count as "prior art" for obviousness purposes? The panel will also consider the Supreme Court's options in this case.
The registration fee for the webinar is $135 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.
Comments